Wexford Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,900
Closed -$353K 205
2017
Q2
$353K Buy
+2,900
New +$353K 0.03% 135
2015
Q2
Sell
-14,515
Closed -$2.52M 80
2015
Q1
$2.52M Buy
+14,515
New +$2.52M 0.73% 26
2013
Q3
Sell
-86,800
Closed -$8.01M 272
2013
Q2
$8.01M Buy
+86,800
New +$8.01M 0.7% 24